Omega-3 Fatty Acids and its future Prospects with References
>
>
Omega-3 Fatty Acids and its future Prospects with References

Dr. Sanjay Agrawal

Leading Pharmaceutical consultant and editor-in chief of IJMToday

Omega-3s are unquestionably beneficial to one’s health at all stages of life. There is substantial evidence for their usefulness in maternal and newborn nutrition, childhood and behavioral disorders, adults, depression and cardiovascular2 illness, and the elderly in terms of cognitive decline. Their advantages transcend the entire age spectrum. Omega-3s are needed at all stages of life, yet it’s not unexpected that we’re dealing with a population with nutritional inadequacies.

Benefits:

Consumption of omega-3 fatty acids may have health implications. Consumption of omega-3 fatty acids in the diet lowers the incidence of age-related eye diseases, including cataracts. Consumption of omega-3 fatty acids also aids in preventing and treating a variety of cardiovascular illnesses. Long-chain omega-3 fatty acids3,4,5regulate hepatic3,4 lipid metabolism in the liver by increasing fatty acid oxidation. It influences different mechanisms that affect endothelial permeability and function. Anti-inflammatory microorganisms are grown in high-EPA and DHA diets, minimizing immune cell damage and inflammation. EPA helps lower the risk of age-related diseases6 like Alzheimer’s and Parkinson’s.

The Importance of Omega-3 Fatty Acids in Immune Function

Omega-3’s clinical applications have been explored and debated for many years, and they have become such an integral element of a healthy lifestyle that they are no longer optional. Despite this, there are periods of the year when people forget that omega-3 can help maintain the immune system, such as during the winter months.

Omega-3’s clinical applications for immunological diseases5 are numerous and studied for decades. The scientists analysed research in-depth. They validated the impact of omega-3 fatty acids on immune system function6,7. The effects of omega-3 fatty acids on macrophages, cytokines, neutrophil function, T cells (including T regulatory cells), B cells, dendritic cells, natural killer cells, mast cells, basophils, and eosinophils are all discussed in the review.

Omega-3 fatty acids, as a constituent of cellular membranes, can influence cellular membrane features such as membrane fluidity and complex assembly in lipid rafts. This isn’t shocking information in and of itself. However, omega-3 fatty acids and their derivatives have recently emerged as signalling molecules. This is assumed to be related to changes in cell signalling, cytokines, and pro-inflammatory mediators disrupting pro-inflammatory pathways.

Interestingly, dietary omega-3 fatty acids increase specialized immune functions in specific immune cell types, such as macrophage and neutrophil phagocytosis or T-reg differentiation, implying that omega-3 fatty acids do not behave as general immune suppressors. As a result, ensuring omega-3 saturation is a year-round focus is essential for achieving optimal immune function.

The future of Omega and current conditions:

ISSFAL8 is an international academic society that represents the majority of researchers in lipids, health, and nutrition. Omega-3 fatty acids are polyunsaturated, and three types are involved in human physiology: alpha-linolenic acid (ALA), which is found in plant oils, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), which are both located in marine oils and are the primary source9 of omega-3s in the diet.

PA and DHA have received more good evaluations from the European Food Safety Authority than any other vitamin. Nine health claims have been approved for use so far, including those related to disease prevention and children’s development and health. This is a testament to the well-established advantages associated with EPA and DHA10, especially given the stringent regulatory system under which the evaluations were done.

As per research, it is believed that more authorized health claims for omega-3s will be seen in the future, but it will take time as the regulatory climate develops. Not only in Europe, but throughout the world, it differs from place to region. Claims aren’t always solely based on their research, and how that science is interpreted can vary. Getting these claims authorized is a long and challenging process. It is even believed that we will see an increase in the number of pure pharmaceutical applications approved over the next five to ten years. The pharma companies are heavily involved in research in this field, looking into omega-3s as first-line or adjuvant therapies across many therapeutic areas.

Over the last two decades, the omega-3 category has exploded in popularity. The market11 is worth an estimated $1.3 billion at the ingredient level and is growing globally. Researchers claim that this is due to the items’ solid and well-established science. After many years of research, there are now several well-established claims for these products, and the science is not only well-established, but it is also evolving.

Scientists argues that, unlike other nutrients, omega-3s saw a burst of scientific and academic activity 10 years ago, as well as a surge in commercial items before fading away. The research advances and new findings emerge every year, providing a boost to the market—perhaps by reinforcing the evidence in one area or opening a new one. As global expendable income rises, people will want to take advantage of these benefits, particularly in Asia; thus, as it is predicted, the market will continue to develop.

With few exceptions, omega-3 insufficiency is a worldwide issue. A few well-studied, well-known tiny populations worldwide consume a lot of dietary fish and have very high omega-3 indices. They are, however, in the minority. We’re seeing their levels drop as their diets alter and adopt a more Western diet.

Sea food esp,Fish oil11, mostly a by-product, provides the great majority of omega-3s. The amount of fish oil used in supplements is a small percentage of total production, with a considerable rate deemed unsuitable12,15 for supplementation. The global population adds as an important causative factor to the insufficiency of the omega 3 oils leading to increased opportunities for development of alternative sources Researchers predict that this will change. Increases in output and differences in processing13 and recovery techniques will result in a higher proportion of fish oil available for human consumption.

In the future, there will be new sources14 accessible that are more sustainable and have higher environmental credentials, such as algae oils, which are now well established. Several organizations are working towards the development of the Omega -3 fatty acid sources from single cell algae from various species. Genetic modification13 technologies have been used in the development of omega-3 from the yeast and other organism are future possibilities. Increased marine pollution, population expansion and overfishing concerning the fish oil manufacturing industry has generated as a boon to the growing land crops to produce omega 3 oils with the assistance of genetic engineering technology.

The continuous research the field of biomedical engineering16 for development of these crops will prove to be beneficial economically, socially, and environmentally. As the acceptance of these crops by the industry and the consumers will be an essential aspect along the setting of health and safety standards by regulatory bodies. Exciting prospects of development of omega -3 oils from various other sources including whole grains, vegetable plant tissue, extracted oil from the food ingredient will be open new avenues of research in field of omega -3 fatty acids.

REFERENCES

  1. https://www.ncbi.nlm.nih.gov/books/NBK564314/ 
  1. https://pubmed.ncbi.nlm.nih.gov/25720716/#:~:text=Omega%2D3%20fatty%20acids%20have,to%20treat%20hyperlipidemia%20and%20hypertension.
  2. https://www.hsph.harvard.edu/nutritionsource/what-should-you-eat/fats-and-cholesterol/types-of-fat/omega-3-fats/
  3. https://pubmed.ncbi.nlm.nih.gov/12480795/#:~:text=Animal%20experiments%20and%20clinical%20intervention,of%20inflammatory%20and%20autoimmune%20diseases.
  4. https://www.ncbi.nlm.nih.gov/books/NBK564314/
  5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834330/
  1. https://www.nutraingredients-usa.com/Article/2019/12/09/ISSFAL-publishes-guidelines-on-analysis-of-omega-3-blood-status-in-clinical-research
  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834330/#:~:text=Omega%2D3%20fatty%20acids%2C%20and,reactive%20oxygen%20species%20and%20cytokines.
  2.  https://www.efsa.europa.eu/en/press/news/120727
  1. https://www.aocs.org/stay-informed/inform-magazine/featured-articles/omega-3-fatty-acids-13-billion-global-market-october-2011?SSO=True
  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257669/
  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262608/
  2. https://www.efsa.europa.eu/en/press/news/120727
  1. https://pubmed.ncbi.nlm.nih.gov/17368277/
  1. https://www.researchgate.net/publication/318259145_Current_Trends_and_Future_Perspectives_on_Omega-3_Fatty_Acids

Abbreviations

EPA = Eicosapentaenoic acid

 DHA = Docosahexaenoic acid

ISSFAL= International Scientific Society

PA = Palmitic Acid

Start typing and press Enter to search

Shopping Cart

No products in the cart.